Clearside Biomedical shares fall 2.17% intraday as Piper Sandler Companies acquires G Squared Capital Partners.

Tuesday, Aug 5, 2025 10:05 am ET1min read
Clearside Biomedical, Inc. declined 2.17% in intraday trading. The news event related to Piper Sandler Companies acquiring G Squared Capital Partners, a boutique investment bank specializing in government services and defense technology, does not directly impact Clearside Biomedical, Inc. Therefore, the cause of the stock's decline is not explicitly clear from the given news events.

Clearside Biomedical shares fall 2.17% intraday as Piper Sandler Companies acquires G Squared Capital Partners.

Comments



Add a public comment...
No comments

No comments yet